Stock data

華廣 (4737)

華廣 is a TWSE-listed company in Biotech & Medical Care. Revenue for September 2026 was NT$180.00M, up 20.9% from a year earlier. EPS over the last four quarters totals -NT$4.00.

Charts, drawing tools, and the P/E calculator are in the app, free to use.

Open 華廣 in Insightr